More Images
The FDA might be preparing to OK a second round of COVID-19 booster shots that target the original virus as well as the Omicron variant to protect people over 65 and others who are particularly vulnerable.

That’s the message from The Wall Street Journal, which published an article Monday citing unnamed sources familiar with discussions.

“The officials are moving toward authorizing the second jabs of the Omicron-targeted shots for people who are 65 years and older or who have weakened immune systems, though the officials haven’t reached a final decision and could change their mind, one of the people said,” The Journal wrote.

The boosters would need to be approved by the CDC for wide distribution. Head over to WebMD to read the full story.